01 December 2005
The effects of non-selective and cyclooxygenase-2-selective non-steroidal anti-inflammatory drugs on heterotopic ossification in rats.
Nergiz Murat, Nil Hocaoglu, Vasfi Karatosun, Kutsal Yorukoglu, Sedef Gidener, Izge GunalMed Sci Monit 2005; 11(12): BR449-451 :: ID: 438847
Abstract
Background: Review of the literature revealed several experimental studieson the effects of selective COX-2 inhibitors on fracture healing, but no reports were encountered regardingthe effects of these compounds on experimental heterotopic bone formation, so the present study was conducted.Material/Methods: Thirty adult male Wistar rats were divided into three groups of ten animals each. Tibialand femoral bones were collected from the rats, cleaned and demineralized, and diaphyseal parts wereimplanted in muscle pouches created in the right gluteal region, one into each rat. Group 1 receivedDFU (5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)phenyl-2(5H)-furanone), a highly selectiveCOX-2 inhibitor, at a dose of 1.1 mg/kg/day. Group 2 received 2 mg/kg/day of indomethacin. The drugswere administered by oral gavage with 0.5% methyl cellulose as a delivery vehicle for eleven days, beginningon the first postoperative day. Group 3 received only methyl cellulose. Results: Thirty days after theimplantation of the demineralized bone matrix, 6/10 of DFU-treated, 9/9 of the indomethacin-treated,and 8/9 of the control rats displayed new bone formation. Conclusions: The results of this study suggestthat no form of non-steroidal anti-inflammatory drug has inhibitory effects on heterotopic bone formationin rats. In our opinion, bone formation is a quite complex process that requires several events and isregulated by several factors, so further investigations other than those using non-steroidal anti-inflammatorydrugs are required.
Keywords: Anti-Inflammatory Agents, Non-Steroidal - therapeutic use, Cyclooxygenase 2 Inhibitors - therapeutic use, Furans - therapeutic use, Indomethacin - therapeutic use, Ossification, Heterotopic - pathology, Rats, Wistar
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
06 Mar 2024 : Clinical Research
Comparison of Outcomes between Single-Level and Double-Level Corpectomy in Thoracolumbar Reconstruction: A ...Med Sci Monit In Press; DOI: 10.12659/MSM.943797
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952